483
RJ General CorporationRJ General Corporation – FDA 483, Jan 12, 2022
Record Details
An FDA inspection of RJ General Corporation, a drug repackager in Cincinnati, OH, revealed significant deficiencies in its quality control unit and batch production records. The firm lacks a defined quality control unit, written procedures for its responsibilities, and proper documentation for critical production steps. These issues indicate a lack of adequate controls to ensure drug product quality and compliance with GMP requirements.
View Company Profile
ID · 36fcd151-86a6-4c6c-b208-f52648f24c02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.